Life Sciences is facing an unprecedented amount of data stemming from wearable, electronic health records and patient claims data. Pending regulations such as General Data Protection Regulation (GDPR) will only increase the focus on data privacy.
This whitepaper highlights the urgency for healthcare organizations to consider IT as a strategic priority in order to stay afloat in the midst of unimagined disruption and the need to maximize their IT investment strategies and optimize IT assets.
Specialty drug costs are so high that the entire pharmaceutical industry is now under scrutiny for its pricing practices. In this piece, we explore the practical approaches to pricing for value that pharma manufacturers can leverage today.